Avita Medical Boosts 2026 Revenue Outlook on Q2 Sales Growth
Avita Medical, a regenerative medicine company, has raised its 2026 revenue outlook to $86 million–$89 million from $80 million–$85 million following a 18% year-over-year increase in Q2 sales to $21.7 million. The compan